Thus, deregulation of transcription can sensitize cancer cells to PARPi, as we previously demonstrated for the Ets‐1 factor, which accumulates in cells and whose transcriptional activity is increased by the inhibition of PARP‐1 [28]. Here, PARP1 is linked to cancer.